BSEBoard Meeting6d ago · 26 Aug 2026, 04:55 pm

Approval of Material Related Party Transaction

Arvaya Healthcare Ltd · 524723

✦ AI SummaryRelated Party

Arvaya Healthcare Ltd has approved a material related party transaction for the acquisition of the copyright and intellectual property portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP for ₹10 Crores, funded from the company's rights issue proceeds.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern6/10
Regulatory Risk4/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Arvaya Healthcare Ltd - 524723 - Board Meeting Outcome for Acquisition Of Copyright And Intellectual Property Portfolio Of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP

Attachments (1)

📄

48d4028e-b291-4306-a915-88d9b17f9ae4.pdf

pdf

Download →
View document text
August 26, 2026 The Secretary, Listing Department Bombay Stock Exchange Ltd Phiroze Jeejeebhoy Towers, Street, Mumbai – 400 001 Reference: Scrip Code: 524723/ ISIN: INE491D01017 Subject: Outcome of Meeting of Board of Directors of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“the Company”) in accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (“Listing Regulation”) Respected Authorities, Pursuant to the Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“the Company”) held today i.e. Wednesday, August 26, 2026 through video conferencing/other audio-visual has inter alia, considered and approved the following amongst other items of agenda: 1. To consider and approve the Material Related Party Transaction with Navahmedi Solution Private Limited for acquisition of its business undertaking (slump sale), including intellectual property, assets and liabilities, out of rights issue proceeds. Subsequent to the circulation of the original Agenda, the Board of Directors, with the unanimous consent of all directors present at the meeting, revised the scope and structure of the proposed transaction and discussed the following item: 1. Acquisition of Copyright and Intellectual Property Portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP The Board considered and approved the Material Related Party Transaction for the acquisition of the Copyright and Intellectual Property (IP) portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP (LLPIN: AAS-7091), comprising identified intellectual property assets, copyrights, and associated rights, title, and interest therein, pursuant to a definitive Copyright & IP Assignment Agreement to be executed between the Company and DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP. Key Details of the Transaction:  Structure: The transaction is structured strictly as an acquisition/assignment of the identified Copyright and IP portfolio. It does not involve the acquisition of the entire business undertaking of the LLP or a slump-sale acquisition of its business.  Consideration: The total consideration for the acquisition shall not exceed ₹10 Crores (Rupees Ten Crores only), based on an independent valuation of the identified IP assets and associated rights.  Mode of Funding: The consideration is proposed to be funded out of the proceeds of the Company’s Rights Issue, subject to compliance with applicable provisions and the objects specified in the Rights Issue documents.  Regulatory Approvals: Being a Material Related Party Transaction, the proposed transaction is subject to compliance with the applicable provisions of the Companies Act, 2013, the rules framed thereunder, and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including obtaining shareholder approval, if applicable.  Documentation & Governance: The draft Copyright & IP Assignment Agreement, valuation report, and material terms were reviewed and recommended by the Audit Committee prior to Board approval. The meeting of Board of Directors of the Company commenced at 3.00 p.m. and concluded at 4:30 p.m. We request you to kindly take the same on your record. Thanking you, Yours faithfully, For and on Behalf of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) Kaushal Uttam Shah Managing Director DIN: 02175130 Place: Pune Date: 26th August 2026 Place: Sangli